Prostate Cancer: Which Therapeutic Option for Which Patient

Top Rated5(1 reviews)

Prostate Cancer: Which Therapeutic Option for Which Patient is a Continuing Professional Development (CPD) course designed for healthcare professionals working in primary care, urology, oncology, nursing, men’s health, radiology, pharmacy, and community healthcare settings. The course provides an evidence-based overview of prostate cancer screening, diagnosis, staging, risk stratification, treatment selection, and multidisciplinary management. Prostate cancer is one of the most commonly diagnosed cancers among men worldwide. Early detection and appropriate management are essential to improving patient outcomes while balancing quality of life considerations. Advances in imaging, pathology, genomics, and treatment strategies have significantly changed prostate cancer diagnosis and management pathways in recent years.

7 Modules1 hour
$169$0
Start Learning
Prostate Cancer: Which Therapeutic Option for Which Patient

Learning Outcomes

What you'll learn

  • Outline routine screening recommendations and early detection methods for prostate cancer.
  • Identify groups at increased risk of prostate cancer in the community.
  • Explain diagnostic pathways including PSA testing, MRI scans, biopsy, and staging investigations.
  • Recognise the grading and staging systems used in prostate cancer assessment.
  • Identify patient risk groups and appropriate therapeutic pathways.
  • Understand the role of multidisciplinary team management in prostate cancer care.
  • Support shared decision-making and patient-centred treatment planning.
  • Recognise the physical and psychosocial impacts of prostate cancer and its treatment.

Stay updated with our

Healthcare trainingHealthcare training

Training Overview

  • Understanding Prostate Cancer and Risk Factors
  • Screening and Early Detection
  • Diagnostic Pathways and Staging Investigations
  • Grading, Staging, and Risk Stratification
  • Therapeutic Options and Multidisciplinary Care
  • Psychosocial Support and Long-Term Survivorship
  • Summary
Healthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare trainingHealthcare training

Top reviews

FA

Faida

User fromcare-learning

5

very informative about prostate cancer

Posted on 27/05/2026

You May Also Like

Take Your
Learning Anywhere

Stay on top of your learning with the Care Learning app.

Download on the App StoreGet it on Google Play

Are you a qualified
Trainer or Instructor?

Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.

Refer a Friend &
Earn Rewards.

Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.

1 / 3

Frequently asked questions

The prostate is a small gland in the male reproductive system located below the bladder.

A PSA test measures prostate-specific antigen levels in the blood and may help identify prostate abnormalities.

The Gleason score is a grading system used to assess prostate cancer aggressiveness based on biopsy findings.

Active surveillance involves close monitoring of low-risk prostate cancer without immediate treatment.

MRI helps identify suspicious lesions and assists in guiding prostate biopsy procedures.

Multidisciplinary care improves treatment planning, coordination, and patient-centred decision-making.